Dr. Mark J. Stavas
Claim this profileSoutheast Nebraska Cancer Center - 68th Street Place
Studies Breast Cancer
Studies Prostate Cancer
5 reported clinical trials
17 drugs studied
Area of expertise
1Breast Cancer
HER2 positive
ER positive
PR positive
2Prostate Cancer
Affiliated Hospitals
Clinical Trials Mark J. Stavas is currently running
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
More about Mark J. Stavas
Clinical Trial Related5 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Mark J. Stavas has experience with
- Apalutamide
- Ipilimumab
- Nivolumab
- Radiation Therapy
- Atezolizumab
- Cisplatin
Breakdown of trials Mark J. Stavas has run
Breast Cancer
Prostate Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mark J. Stavas specialize in?
Mark J. Stavas focuses on Breast Cancer and Prostate Cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are ER positive.
Is Mark J. Stavas currently recruiting for clinical trials?
Yes, Mark J. Stavas is currently recruiting for 3 clinical trials in Lincoln Nebraska. If you're interested in participating, you should apply.
Are there any treatments that Mark J. Stavas has studied deeply?
Yes, Mark J. Stavas has studied treatments such as Apalutamide, Ipilimumab, Nivolumab.
What is the best way to schedule an appointment with Mark J. Stavas?
Apply for one of the trials that Mark J. Stavas is conducting.
What is the office address of Mark J. Stavas?
The office of Mark J. Stavas is located at: Southeast Nebraska Cancer Center - 68th Street Place, Lincoln, Nebraska 68516 United States. This is the address for their practice at the Southeast Nebraska Cancer Center - 68th Street Place.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.